Shah, whose company developed the oral testosterone drug Kyzatrex, urged regulators to broaden treatment access and align policy with modern science and preventive healthcare goals.
Shah, whose company developed the oral testosterone drug Kyzatrex, urged regulators to broaden treatment access and align policy with modern science and preventive healthcare goals.
Marius Pharmaceuticals, which helped secure FDA removal of Black Box Warning, says regulatory shift marks a milestone for patient access and treatment options.
The American Bazaar is a publication of American Bazaar, Inc., based in Germantown, MD.
